@jimmy-ly.bsky.social

How can cells maintain gene expression despite minimal transcription during prolonged mitotic arrest? @iaincheeseman.bsky.social @jimmy-ly.bsky.social et al reveal global transcriptome stabilization in mitotic cells, partly because of reduced mRNA deadenylation link.springer.com/article/10.1...

Global stabilization of the transcriptome in mitotic cells - The EMBO Journal

In the presence of cell division errors, mammalian cells can pause in mitosis for tens of hours with little to no transcription, while still requiring continued translation for viability. These unique aspects of mitosis require substantial adaptations to gene expression. During interphase, homeostatic control of mRNA levels involves a constant balance of transcription and degradation, with a median mRNA half-life of ~2–4 h. If such short half-lives persisted in mitosis, cells would be expected to rapidly deplete their transcriptome without new transcription. Here, we report that the transcriptome is globally stabilized during prolonged mitotic delays. Median mRNA half-lives are increased >4-fold during mitotic arrest compared to interphase, buffering mRNA levels in the absence of new synthesis. Moreover, poly(A) tail-length profiles change during mitotic arrest, strongly suggesting a partial mitotic repression of deadenylation. In contrast, siRNA-directed mRNA degradation machinery remains active. We further show that mitotic mRNA stabilization depends on PABPC1&4. Depletion of PABPC1&4 during mitotic arrest reduces mRNA stability and disrupts the cells’ ability to maintain arrest, highlighting the critical physiological role of mitotic transcriptome buffering.

link.springer.com

Rare disease treatment relies on the combined efforts of clinicians, researchers, and families. Yet these people rarely find themselves in the same room. BridgeRD brought them together last week to address the challenges of understanding, diagnosing, and treating rare diseases. 🔗 shorturl.at/pJXcu

Scientists and clinicians convene to bridge gaps in rare disease research and care | Whitehead Institute

Rare disease treatment and care relies on the combined efforts of clinicians, researchers, and families. Yet these people rarely find themselves in the same room. BridgeRD brought together stakeholder...

shorturl.at

New preprint! Graduate student Océane Marescal leverages quiescence - proliferative hibernation - to reveal unexpected dynamics for “constitutively”-localized centromere proteins. To understand the logic of cell division, you need to consider non-dividing cells. www.biorxiv.org/content/10.1...

The dynamics of centromere assembly and disassembly during quiescence

Quiescence is a state in which cells undergo a prolonged proliferative arrest while maintaining their capacity to reenter the cell cycle. Here, we analyze entry and exit from quiescence, focusing on h...

biorxiv.org

New preprint! We solve a mystery you didn't know existed. Mitotic cells lack new transcription but require ongoing translation. Interphase mRNA half life is only 2-4 hrs. So how do cells arrest in mitosis for hours without depleting their transcriptomes? www.biorxiv.org/content/10.1...

Global inhibition of deadenylation stabilizes the transcriptome in mitotic cells

In the presence of cell division errors, mammalian cells can pause in mitosis for tens of hours with little to no transcription, while still requiring continued translation for viability. These unique...

biorxiv.org

Countdown to an epic new pre-print. Mitochondria are cells within our cells. They need the same core activities - replication, transcription, translation. How do cells enable these diverse activities in both compartments? We uncover an unexpected + broad strategy with ancient origins. Stay tuned!